Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Australia / NCT06983808
Recruiting Not applicable

The PREBEAT Trial: Digital PREhaBilitation in thE Cardiac Surgical populATion

NCT06983808 · tracked via the Priya Life Science Australia tracker
Sponsor
Claire Hines
Phase
Not applicable
Started
2026-01-28
Last updated
2026-06-11

Condition(s) studied

Cardiovascular Diseases

Investigational drug(s) / intervention(s)

Digital Cardiac PrehabilitationControl (Standard treatment)

Digital Cardiac Prehabilitation: Digital Cardiac Prehabilitation - A combined telehealth and app-based preparation for cardiac surgery

Control (Standard treatment): Standard preparation for surgery as per Melbourne Health hospital procedures and processes. This may include information sessions, pamphlets, and meetings with clinicians. This does not include a prehabilitation program.

Study summary

The goal of this randomised controlled trial is to learn if a digital prehabilitation program is feasible in patients awaiting cardiac surgery. The main questions it aims to answer are:

1. Is the digital health program usable?
2. Is the digital health program acceptable?
3. Do patients adhere to the digital health program?

Researchers will compare a group using the digital prehabilitation program with standard care to see if the program is feasible and explore any differences in health outcomes.

Participants will

* Use a digital health mobile phone application to guide you through exercise, nutrition and preparation for surgery.
* Engage in telehealth consultations.
* Complete questionnaires
* Complete exercise testing

Eligibility

Sex
ALL
Min age
18 Years
Max age
100 Years
Healthy volunteers
No
Inclusion Criteria: * 21 days+ prior to cardiac surgery * Able to provide consent, * Proficient in English to understand questionnaires, training instructions and outcome assessments. * Digitally literate to independently navigate a smart device and novel application. Exclusion Criteria: * severe or unstable neurological, cardiorespiratory, or musculoskeletal disease or mental illness that might compromise ability to perform exercise, * unstable psychiatric or cognitive disorders,

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Melbourne Health (Royal Melbourne and Melbourne Private Hospital) Melbourne Victoria Recruiting

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06983808 on ClinicalTrials.gov ↗ ← All trials in Australia